NEUROPATHIX, INC. — Form D
NEUROPATHIX, INC. of DOYLESTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-14. The offering totals $3.0M, of which $100K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-01-14
- Form: D
- Accession: 0001607062-20-000013
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $100K
- Remaining: $2.9M
- Investors: 1
- Date of first sale: 2019-12-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-358038
Issuer
- Name: NEUROPATHIX, INC.
- CIK: 0001615999
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Phone: 2156956559
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Dead Petkanas | Director | Doylestown, PA |
| Mark Corrao | Executive Officer | Miramar, FL |
| Dead Petkanas | Executive Officer | Doylestown, PA |
| Dead Petkanas | Promoter | Doylestown, PA |
| Dean Petkanas | Director | Lloyd Harbor, NY |
| Dean Petkanas | Executive Officer | Lloyd Harbor, NY |
| Robert Malasek | Director | Doylestown, PA |
| Robert Malasek | Executive Officer | Doylestown, PA |
| Timothy Scott | Director | Doylestown, PA |
| William Kinney | Executive Officer | Doylestown, PA |
| Blake Schroeder | Director | Dallas, TX |
| Thomas Kikis | Director | Doylestown, PA |
| Thomas Kikis | Executive Officer | Doylestown, PA |
Other filings by this issuer (3)
More